The Estée Lauder Companies Inc. is set to report its fiscal second-quarter 2026 earnings on February 5, with investors closely watching signs of revenue...
Veradermics moved ahead with its market debut this week, pricing an upsized U.S. IPO at $17 per share—above the previously indicated range—underscoring unexpectedly strong...
Cencora Inc. is heading into its first-quarter earnings report with investor expectations firmly anchored on steady revenue growth and resilient margins, even as the...
GenFlat Holdings, an early-stage developer of collapsible marine shipping containers, priced its U.S. initial public offering at the low end of expectations, raising $7...